Dextromethorphan · more major-labeled pairs than Brexpiprazole
SPL labels Brexpiprazole + Dextromethorphan as minor; Brexpiprazole 9 / Dextromethorphan 11 in that band.
Mechanism on file: Brexpiprazole does not interfere with the liver enzymes that your body uses to break down dextromethorphan.
FDA SPL severity: Minor
Brexpiprazole + Dextromethorphan · SPL mechanism field
Brexpiprazole does not interfere with the liver enzymes that your body uses to break down dextromethorphan.
Minor band excerpt · Brexpiprazole with Dextromethorphan
Additionally, no dosage adjustment for substrates of CYP2D6 (e.g., dextromethorphan), CYP3A4 (e.g., lovastatin), CYP2B6 (e.g., bupropion), BCRP (e.g., rosuvastatin), or P-gp (e.g., fexofenadine) is required when administered concomitantly with REXULTI.
Brexpiprazole · 9 minor + 9 total pairs
- Bupropion minor
- Fexofenadine minor
- Fluoxetine minor
- Lovastatin minor
Dextromethorphan · 1 major-labeled pairs (vs Brexpiprazole's 0)
- Abiraterone minor
- Aripiprazole minor
- Desvenlafaxine minor
- Fluvoxamine minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.